Pall Biotech and G-CON manufacturing have partnered to design and deploy an integrated manufacturing solution to address the current capacity constraints for viral vector manufacturing.
Participants will learn:
– The manufacturing challenges facing the viral vector industry
– The advantages of an integrated manufacturing solution
– How to develop and deploy a new manufacturing facility in 10 months within a modular cleanroom
